Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2000
11/22/2000EP1053021A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
11/22/2000EP1053020A1 Absorbable microparticles
11/22/2000EP1053019A1 Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom
11/22/2000EP1053014A1 BIOLOGICALLY ACTIVE HEMAGGLUTININ FROM TYPE A $i(CLOSTRIDIUM BOTULINUM) AND METHODS OF USE
11/22/2000EP1053012A1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections
11/22/2000EP1053010A1 Copolymer compositions for oral delivery
11/22/2000EP1052995A1 Pharmaceutical composition for nasal administration of thiocolchicoside
11/22/2000EP1052987A1 Tablets to be crunched or sucked, comprising iron as active principle
11/22/2000EP1052977A1 Treatment of chronic inflammatory disorders of the gastrointestinal tract
11/22/2000EP1052975A1 Propofol composition containing sulfite
11/22/2000EP1052974A2 Compositions containing organic compounds
11/22/2000EP0725637B1 Parenteral busulfan for treatment of malignant disease
11/22/2000EP0705255B1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes
11/22/2000EP0586535B1 Methods and compositions based on inhibition of cell invasion and fibrosis by dextran sulfate
11/22/2000CN1274286A Parenteral formulations comprising carbamazepine or its derivatives
11/22/2000CN1274280A Delayed total release gastrointestinal drug delivery system
11/22/2000CN1274279A Film-coated tablet for improved upper gastrointestinal tract safety
11/22/2000CN1273861A Low sustituted ethylene-lactic cellulose and solid preparation
11/22/2000CN1273860A Medicine for treating blood vessel embolism and its preparing process
11/22/2000CN1058706C Prostaglandin derivative
11/22/2000CN1058608C Method of medicinal compsns. fed by non-galenic form
11/21/2000US6150583 Transgenic animals expressing artificial epitope-tagged proteins
11/21/2000US6150506 Globin-like polypeptide having two dialpha domains; synthetic blood; antiischemic agents; antihypoxia agents; drug delivery; in vivo imaging; treatment of sickle cell anemia
11/21/2000US6150472 Block copolymers crosslinked to polysaccharide with cellulose derivatiiives, polyacrylic acid, polyethers and polyethylenimine,
11/21/2000US6150459 Comb polymers for regulating cell surface interactions
11/21/2000US6150422 Stable gelled composition containing lipophilic active agents sensitive to oxygen and/or water
11/21/2000US6150418 Propellant-free concentrate suitable for storage containing given concentration of formoterol, or salt or addition products thereof as active substance in a solvent or suspension agent; use in inhalation therapy
11/21/2000US6150407 In a tissue or organ by contacting with a compound of given formula such as methyl-3,5-diiodo-4-(4'-methoxyphenoxy)benzoate; reducing the level of tumor necrosis factor alpha
11/21/2000US6150346 Method and composition for treating or preventing osteoporosis
11/21/2000US6150341 Reacting the 5'oh group of vb12 or an analogue thereof with a bifunctional carbonyl electrophile to form an active intermediate, and subsequently reacting the intermediate with a nucleophilic spacer molecule to yield vb12 derivative
11/21/2000US6150331 Human growth hormone-containing aqueous pharmaceutical composition
11/21/2000US6150327 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
11/21/2000US6150168 Complex containing a binding molecule which non-covalently binds to the nucleic acid and covalently links to a surface ligand and a nuclear ligand; for gene therapy
11/21/2000US6150153 Thermostable trehalose-releasing enzyme
11/21/2000US6149944 Mixing aqueous phase containing water-soluble betalactam antibiotic agent and/or inhibitor of betalactamase and organic phase comprising biodegradable polymer is dissolved in solvent, dispersing, adding to aqueous phase; desolventizing
11/21/2000US6149943 Active drug is layered onto tcore via solution coating; coated particles have arrower particle size distribution
11/21/2000US6149941 Taste of active pharmaceutical ingredients
11/21/2000US6149938 Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets and compositions obtained thereby
11/21/2000US6149936 DNA expression vectors for the use in the gene therapeutic treatment of vascular disorders
11/21/2000US6149922 Vaccine adjuvant and vaccine
11/21/2000US6149914 A mixture comprising a dried, powdered interior bark from the sacred fig tree of india, and a rice pudding
11/21/2000US6149211 Inclusion of tooth whitening oxidation chemistries into slow releasing food products
11/21/2000CA2117528C Facilitated oxygen delivery in conjunction with hemodilution
11/21/2000CA2098294C Directly compressible xylitol and method
11/21/2000CA2054189C Stable ascorbic acid compositions
11/21/2000CA2038578C Delivery of agents
11/21/2000CA2031150C Sustained-release drug dosage units
11/21/2000CA2020477C Sustained release formulations of water soluble peptides
11/21/2000CA2010085C Pentamidine solutions
11/18/2000CA2684454A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
11/16/2000WO2000067917A1 Permeabilizing biofilms
11/16/2000WO2000067801A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/16/2000WO2000067800A2 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates
11/16/2000WO2000067799A1 Compositions for treatment of disorders of the oesophagus
11/16/2000WO2000067798A2 Enhanced delivery of nucleic acid-based drugs
11/16/2000WO2000067796A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/16/2000WO2000067793A1 Death domain containing receptor 4
11/16/2000WO2000067772A1 Galenic formulations of argatroban for subcutaneous administration
11/16/2000WO2000067766A1 Restorative and regenerative preparation, method for producing the same and therapeutical use according to l.v. dubinina
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067753A1 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
11/16/2000WO2000067743A1 Radical scavenger
11/16/2000WO2000067730A1 Drug delivery device
11/16/2000WO2000067728A2 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/16/2000WO2000067727A1 Galenic formulations of antithrombotic agents for subcutaneous administration
11/16/2000WO2000067702A1 Cosmetic or pharmaceutical utilisation of nanoscalic metal soaps
11/16/2000WO2000067697A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000WO2000067592A1 Methods for lowering viscosity of glucomannan compositions
11/16/2000WO2000067579A1 Stabilization of isothiazolone
11/16/2000WO2000056336A3 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin
11/16/2000WO2000053633A3 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
11/16/2000WO2000053228A3 Use of niaouli essential oil as transdermal permeation enhancer
11/16/2000WO2000042168A3 Bifidobacterium in the treatment of inflammatory disease
11/16/2000WO2000039285A3 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
11/16/2000WO2000038625A3 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants
11/16/2000WO2000037057A3 Novel formulations comprising lipid-regulating agents
11/16/2000WO2000035432A3 Improved viscoelastic compositions and methods of use
11/16/2000WO2000033874B1 Boron neutron capture therapy using pre-targeting methods
11/16/2000WO2000033825A3 Compositions and methods for amelioration of human female sexual dysfunction
11/16/2000WO2000032186A3 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
11/16/2000WO2000032174A3 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide
11/16/2000WO2000022110A3 Targeted proteolysis by recruitment to ubiquitin protein ligases
11/16/2000WO2000020556A3 Zinc finger-reactive antimicrobial compounds
11/16/2000WO2000018365A3 Fast dissolving orally consumable films
11/16/2000WO2000018316A3 Sustained release, and comfortable ophthalmic composition and method for ocular therapy
11/16/2000WO2000007543A8 Conjugates targeted to the interleukin-2 receptors
11/16/2000WO2000000157A3 Use of tempo and tempo derivatives for inducing cell death
11/16/2000DE19920555A1 Verwendung von nanoskaligen Metallseifen The use of nanoscale metal soaps
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373851A1 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000CA2373447A1 Permeabilizing biofilms
11/16/2000CA2373063A1 Death domain containing receptor 4
11/16/2000CA2372812A1 Stabilization of isothiazolone
11/16/2000CA2372649A1 Methods for lowering viscosity of glucomannan compositions
11/16/2000CA2372461A1 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates
11/16/2000CA2371095A1 Enhanced delivery of nucleic acid-based drugs
11/16/2000CA2369594A1 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/16/2000CA2369328A1 Drug delivery device
11/16/2000CA2368831A1 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/15/2000EP1052288A1 Complex for transferring an anionic substance of interest into a cell
1 ... 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 ... 1712